Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/134097
Title: The surgical treatment of squamous cell carcinoma of the oesophagus in Singapore.
Authors: Wong, T.H.
Tekant, Y.
Ngoi, S.S. 
Ti, T.K. 
Rauff, A. 
Issue Date: Nov-1990
Source: Wong, T.H., Tekant, Y., Ngoi, S.S., Ti, T.K., Rauff, A. (1990-11). The surgical treatment of squamous cell carcinoma of the oesophagus in Singapore.. Annals of the Academy of Medicine Singapore 19 (6) : 807-810. ScholarBank@NUS Repository.
Abstract: In a retrospective study, we reviewed 97 consecutive cases of squamous cell carcinoma collected over a five-year period (1978-1983). Resection of the tumour was possible in 30 out of 40 patients subjected to surgery. Of these 30 patients, five died within 30 days of surgery. Eight patients who underwent oesophageal resection were still alive after five years and apparently cured. Bypass surgery for unresectable lesions in six patients were complicated by anastomotic leakage in three patients. Patients unsuitable for surgical resection were treated using Celestin tube insertion or radiation. Mean survival in 13 patients with Celestin tube insertion was 4.1 months. Of 48 patients who were treated by radiotherapy, two lived beyond five years. Surgical resection restores swallowing effectively and offers a 25% chance of cure and should be done in fit patients. In unfit patients with advanced disease, palliation from the use of radiotherapy and Celestin tube insertion were poor. Newer techniques such as endoscopic laser recanalisation and bicap hyperthermia may need to be considered for palliation in this group of patients.
Source Title: Annals of the Academy of Medicine Singapore
URI: http://scholarbank.nus.edu.sg/handle/10635/134097
ISSN: 03044602
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

8
checked on Jan 20, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.